These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 7570733)

  • 1. Time dependency of the acetazolamide effect on cerebral hemodynamics in patients with chronic occlusive cerebral arteries. Early steal phenomenon demonstrated by [15O]H2O positron emission tomography.
    Kuwabara Y; Ichiya Y; Sasaki M; Yoshida T; Masuda K
    Stroke; 1995 Oct; 26(10):1825-9. PubMed ID: 7570733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of adenosine on cerebral blood flow as evaluated by single-photon emission computed tomography in normal subjects and in patients with occlusive carotid disease. A comparison with acetazolamide.
    Soricelli A; Postiglione A; Cuocolo A; De Chiara S; Ruocco A; Brunetti A; Salvatore M; Ell PJ
    Stroke; 1995 Sep; 26(9):1572-6. PubMed ID: 7660400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intracerebral steal after acetazolamide administration].
    Vastagh I; Pozsár M; Folyovich A; Debreczeni R; Pálvölgyi L; Bereczki D; Szirmai I
    Ideggyogy Sz; 2008 May; 61(5-6):168-73. PubMed ID: 18567392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posthyperventilatory steal response in chronic cerebral hemodynamic stress: a positron emission tomography study.
    Nariai T; Senda M; Ishii K; Wakabayashi S; Yokota T; Toyama H; Matsushima Y; Hirakawa K
    Stroke; 1998 Jul; 29(7):1281-92. PubMed ID: 9660374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis of hemodynamic compromise in patients with chronic cerebral ischemia; the detection of impaired vasodilatory capacity with 133Xe SPECT and acetazolamide (Diamox) test].
    Kuroda S; Takigawa S; Kamiyama H; Abe H; Sakuragi M; Motomiya M; Nakagawa T; Mitsumori K; Tsuru M
    No Shinkei Geka; 1990 Feb; 18(2):167-73. PubMed ID: 2336145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of combination therapy with the angiotensin receptor blocker losartan plus hydrochlorothiazide on brain perfusion in patients with both hypertension and cerebral hemodynamic impairment due to symptomatic chronic major cerebral artery steno-occlusive disease: a SPECT study.
    Saura H; Ogasawara K; Suzuki T; Kuroda H; Yamashita T; Kobayashi M; Terasaki K; Ogawa A
    Cerebrovasc Dis; 2012; 33(4):354-61. PubMed ID: 22433127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arterial Spin Labeling Perfusion Magnetic Resonance Image with Dual Postlabeling Delay: A Correlative Study with Acetazolamide Loading (123)I-Iodoamphetamine Single-Photon Emission Computed Tomography.
    Haga S; Morioka T; Shimogawa T; Akiyama T; Murao K; Kanazawa Y; Sayama T; Arakawa S
    J Stroke Cerebrovasc Dis; 2016 Jan; 25(1):1-6. PubMed ID: 26387043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SPECT measurements of cerebral blood volume before and after acetazolamide in occlusive cerebrovascular diseases.
    Inoue Y; Momose T; Machida K; Honda N; Nishikawa J; Sasaki Y
    Radiat Med; 1994; 12(5):225-9. PubMed ID: 7863027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET evaluation of cerebral hemodynamics in occlusive cerebrovascular disease pre- and postsurgery.
    Kuwabara Y; Ichiya Y; Sasaki M; Yoshida T; Fukumura T; Masuda K; Fujii K; Fukui M
    J Nucl Med; 1998 May; 39(5):760-5. PubMed ID: 9591570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoreactive effect of acetazolamide as a function of time with sequential PET 15O-water measurement.
    Hayashida K; Tanaka Y; Hirose Y; Kume N; Iwama T; Miyake Y; Ishida Y; Matsuura H; Miyake Y; Nishimura T
    Nucl Med Commun; 1996 Dec; 17(12):1047-51. PubMed ID: 9004301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative measurement of regional cerebrovascular reactivity to acetazolamide using 123I-N-isopropyl-p-iodoamphetamine autoradiography with SPECT: validation study using H2 15O with PET.
    Ogasawara K; Ito H; Sasoh M; Okuguchi T; Kobayashi M; Yukawa H; Terasaki K; Ogawa A
    J Nucl Med; 2003 Apr; 44(4):520-5. PubMed ID: 12679394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebellar vascular response to acetazolamide in crossed cerebellar diaschisis: a comparison of 99mTc-HMPAO single-photon emission tomography with 15O-H2O positron emission tomography.
    Kuwabara Y; Ichiya Y; Sasaki M; Akashi Y; Yoshida T; Fukumura T; Masuda K
    Eur J Nucl Med; 1996 Jun; 23(6):683-9. PubMed ID: 8662103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracerebral steal phenomenon in symptomatic carotid artery disease.
    Hartkamp NS; Hendrikse J; de Borst GJ; Kappelle LJ; Bokkers RPH
    J Neuroradiol; 2019 May; 46(3):173-178. PubMed ID: 30389512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative evaluation using single-photon emission computed tomography with acetazolamide is reliable for preoperative evaluation before cardiac surgery in severe carotid intracranial artery stenotic and/or occlusive disease: a case report.
    Tayama E; Mori R; Ueda T; Imasaka KI; Tomita Y; Morita S
    J Cardiothorac Surg; 2019 Jul; 14(1):141. PubMed ID: 31337418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compromised cerebral blood flow reactivity is a predictor of stroke in patients with symptomatic carotid artery occlusive disease.
    Webster MW; Makaroun MS; Steed DL; Smith HA; Johnson DW; Yonas H
    J Vasc Surg; 1995 Feb; 21(2):338-44; discussion 344-5. PubMed ID: 7853605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced blood flow response to acetazolamide reflects pre-existing vasodilation and decreased oxygen metabolism in major cerebral arterial occlusive disease.
    Yamauchi H; Okazawa H; Kishibe Y; Sugimoto K; Takahashi M
    Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1349-56. PubMed ID: 12271418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of delayed appearance of acetazolamide effect in patients with chronic cerebrovascular ischemic disease: feasibility and usefulness of SPECT method using triple injection of ECD.
    Murakami M; Yonehara T; Takaki A; Fujioka S; Hirano T; Ushio Y
    J Nucl Med; 2002 May; 43(5):577-83. PubMed ID: 11994517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse effects of intravenous acetazolamide administration for evaluation of cerebrovascular reactivity using brain perfusion single-photon emission computed tomography in patients with major cerebral artery steno-occlusive diseases.
    Saito H; Ogasawara K; Suzuki T; Kuroda H; Kobayashi M; Yoshida K; Kubo Y; Ogawa A
    Neurol Med Chir (Tokyo); 2011; 51(7):479-83. PubMed ID: 21785240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasomotor reactivity and pattern of collateral blood flow in severe occlusive carotid artery disease.
    Müller M; Schimrigk K
    Stroke; 1996 Feb; 27(2):296-9. PubMed ID: 8571426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between vasodilatation and cerebral blood flow increase in impaired hemodynamics: a PET study with the acetazolamide test in cerebrovascular disease.
    Okazawa H; Yamauchi H; Toyoda H; Sugimoto K; Fujibayashi Y; Yonekura Y
    J Nucl Med; 2003 Dec; 44(12):1875-83. PubMed ID: 14660711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.